NDC 70518-2802

Insulin Lispro

Insulin Lispro

Insulin Lispro is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Insulin Lispro.

• Product ID: 70518-2802_ad192e16-71c3-7155-e053-2a95a90a57a4
• NDC: 70518-2802
• Product Type: Human Prescription Drug
• Proprietary Name: Insulin Lispro
• Generic Name: Insulin Lispro
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS; SUBCUTANEOUS
• Marketing Start Date: 2020-06-30
• Marketing Category: BLA / BLA
• Application Number: BLA020563
• Labeler Name: REMEDYREPACK INC.
• Substance Name: INSULIN LISPRO
• Active Ingredient Strength: 100 [iU]/mL
• Pharm Classes: Insulin [Chemical/Ingredient],Insulin Analog [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 70518-2802-0

1 VIAL in 1 CARTON (70518-2802-0) > 10 mL in 1 VIAL (70518-2802-1)

• Marketing Start Date: 2020-06-30
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Insulin Lispro" or generic name "Insulin Lispro"

NDC	Brand Name	Generic Name
66733-773	Insulin lispro	Insulin lispro
70518-2398	Insulin lispro	Insulin lispro
0002-7737	Insulin Lispro	Insulin Lispro
70518-2802	Insulin Lispro	Insulin Lispro
50090-5391	Insulin Lispro	Insulin Lispro
0002-7510	Humalog	Insulin lispro
0002-7511	Humalog	Insulin lispro
0002-7512	Humalog	Insulin lispro
0002-7516	Humalog	Insulin lispro
0002-7712	Humalog	Insulin lispro
0002-7714	Humalog	Insulin lispro